1347374: NEOSTIGMINE METHYLSULFATE INJECT.
NEOSTIGMINE METHYLSULFATE INJECT. Key specifications include administration: INTRAVENOUS, primary_container_type: VIAL, protective_storage_feature: CONTROLLED ROOM TEMPERATURE OR PROTECT FROM DIRECT SUNLIGHT, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, total_primary_container_quantity: 10, primary_container_content_quantity: 10.000 MILLILITERS. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-646-4005, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | INTRAVENOUS |
| special_features | NEOSTIGMINE METHYLSULFATE INJECTION 1MG/ML 10ML 10S; FOR INTRAVENOUS USE ONLY; STORE AT 20 TO 25 C (68 TO 77 F); PROTECT FROM LIGHT; STORE VIALS IN TRAY OR CARTON UNTIL READY TO USE |
| primary_container_type | VIAL |
| protective_storage_feature | CONTROLLED ROOM TEMPERATURE OR PROTECT FROM DIRECT SUNLIGHT |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| total_primary_container_quantity | 10 |
| primary_container_content_quantity | 10.000 MILLILITERS |
| active_medicament_medicinal_strength | 1.00 MILLIGRAMS NEOSTIGMINE METHYLSULFATE PER MILLILITER |
| part_name_assigned_by_controlling_agency | NEOSTIGMINE METHYLSULFATE INJECTION, FOR INTRAVENOUS USE |
| NSN | 6505-01-646-4005 |
| ADMINISTRATION | INTRAVENOUS |
| PRIMARY CONTAINER CONTENT QUANTITY | 10.000 MILLILITERS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | VIAL |
| SPECIAL FEATURES | NEOSTIGMINE METHYLSULFATE INJECTION 1MG/ML 10ML 10S; FOR INTRAVENOUS USE ONLY; STORE AT 20 TO 25 C (68 TO 77 F); PROTECT FROM LIGHT; STORE VIALS IN TRAY OR CARTON UNTIL READY TO USE |
| PROTECTIVE STORAGE FEATURE | CONTROLLED ROOM TEMPERATURE OR PROTECT FROM DIRECT SUNLIGHT |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | NEOSTIGMINE METHYLSULFATE INJECTION, FOR INTRAVENOUS USE |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 1.00 MILLIGRAMS NEOSTIGMINE METHYLSULFATE PER MILLILITER |
| TOTAL PRIMARY CONTAINER QUANTITY | 10 |